SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortec (CRTQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgAuUSA who wrote (3)11/25/1996 9:54:00 PM
From: E.J. Neitz Jr   of 22
 
Greg--CRTQ Experiencing Extreme Tax-Loss Selling

As you are probably aware they recently suspended a trial involving Pfizer when some mice died. The company is trying to determine the reason for this--procedures or whatever--however, there were no adverse effects on humans. With this the stock sold off and more selling followed. What most 'investors' forget is that CRTQ has numerous other studies going on with various partners. Also the company has a very good cash position and book value is around the current stock price. I have been involved in similiar situations like this around tax selling time and I have gone against the crowd and bought more bio-tech shares as the price dropped--I never regretted those buys. I am ready to really step up my buying in this stock. As for Sturza--I have not heard anything to indicate he has changed his buy on this one-- he should be pounding the table on this soon---especially at this price. Best wishes. Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext